Correction: Multi-omics analysis unveils the predictive value of IGF2BP3/SPHK1 signaling in cancer stem cells for prognosis and immunotherapeutic response in muscle-invasive bladder cancer

Correction: Multi-omics analysis unveils the predictive value of IGF2BP3/SPHK1 signaling in cancer stem cells for prognosis and immunotherapeutic response in muscle-invasive bladder cancer

Saved in:

Bibliographic Details
Main Authors:	Yaobang Wang, Wuyue Song, Chao Feng, Shulin Wu, Zezu Qin, Tao Liu, Yu Ye, Rong Huang, Yuanliang Xie, Zhong Tang, Qiuyan Wang, Tianyu Li
Format:	Article
Language:	English
Published:	BMC 2025-08-01
Series:	Journal of Translational Medicine
Online Access:	https://doi.org/10.1186/s12967-025-06717-7
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Multi-omics analysis unveils the predictive value of IGF2BP3/SPHK1 signaling in cancer stem cells for prognosis and immunotherapeutic response in muscle-invasive bladder cancer
by: Yaobang Wang, et al.
Published: (2024-10-01)

Immunotherapeutic strategies for invasive bladder cancer: a comprehensive review
by: Yingying Wang, et al.
Published: (2025-04-01)

Exosome-transmitted LUCAT1 promotes stemness transformation and chemoresistance in bladder cancer by binding to IGF2BP2
by: Yonghao Zhan, et al.
Published: (2025-03-01)

The role of IGF2BP3/SPOP/c-Myc loop in paclitaxel resistance of endometrial cancer
by: Yidong Ge, et al.
Published: (2025-04-01)

An immune relevant signature for predicting prognoses and immunotherapeutic responses in patients with muscle‐invasive bladder cancer (MIBC)
by: Wen Jiang, et al.
Published: (2020-04-01)

Unveiling a novel model of cell senescence-related genes for prognostic assessment and immunotherapeutic insights in gastric cancer
by: Gang Wang, et al.
Published: (2025-02-01)

Comprehensive Pan-Cancer Analysis Identifies IGFL1 as an Oncogenic Biomarker and Immunotherapeutic Target with Experimental Validation in Bladder Cancer
by: Liang Z, et al.
Published: (2025-07-01)

RETRACTED ARTICLE: Long non-coding RNA 91H regulates IGF2 expression by interacting with IGF2BP2 and promotes tumorigenesis in colorectal cancer
by: Tianyi Gao, et al.
Published: (2020-01-01)

Integrated multi-omics analysis reveals the immunotherapeutic significance of tumor cells with high FN1 expression in ovarian cancer
by: Xinyi Zhang, et al.
Published: (2025-06-01)

Author Correction: The role of IGF2BP3/SPOP/c-Myc loop in paclitaxel resistance of endometrial cancer
by: Yidong Ge, et al.
Published: (2025-07-01)

Knockdown of IGF2BP2 overcomes cisplatin-resistance in lung cancer through downregulating Spon2 gene
by: Shilei Zhang, et al.
Published: (2024-12-01)

Current Immunotherapeutic Approaches in Pancreatic Cancer
by: Shigeo Koido, et al.
Published: (2011-01-01)

Targeting inflammasomes as an immunotherapeutic strategy for cancer
by: Luanluan Huang, et al.
Published: (2025-06-01)

The biological roles and molecular mechanisms of m6A reader IGF2BP1 in the hallmarks of cancer
by: Li Qiu, et al.
Published: (2025-09-01)

Pan-Cancer Analysis of the Prognostic and Immunotherapeutic Value of PDGFB
by: Bai Y, et al.
Published: (2025-01-01)

Role of extracellular vesicles in cancer: implications in immunotherapeutic resistance
by: Shuai Wang, et al.
Published: (2025-05-01)

IGF2BP3 prefers to regulate alternative splicing of genes associated with the progression of gastric cancer in AGS cells
by: Xiangyue Zeng, et al.
Published: (2025-02-01)

Designs of NKG2D-based immunotherapeutics for cancer
by: Jianfeng Han, et al.
Published: (2025-06-01)

eQTL and multi-omics integration reveal PPIH as a prognostic and immunotherapeutic biomarker
by: Fenglin Lv, et al.
Published: (2025-08-01)

Prognostic and immunotherapeutic potential of disulfidptosis-associated signature in pancreatic cancer
by: Ran Cui, et al.
Published: (2025-03-01)

Clinical and prognostic significance of m6A hypomethylation and IGF2BP3 overexpression in gastric cancer: an integrated epigenomic-transcriptomic analysis
by: Xiangchen Hu, et al.
Published: (2025-08-01)

IGF2BP3 recruits NUDT21 to regulate SPTBN1 alternative polyadenylation and drive ovarian cancer progression
by: Xin Luo, et al.
Published: (2025-04-01)

Methuosis key gene ARF6 as a diagnostic, prognostic and immunotherapeutic marker for prostate cancer: based on a comprehensive pan-cancer multi-omics analysis
by: Yongjin Yang, et al.
Published: (2025-05-01)

GRK5 as a Novel Therapeutic Target for Immune Evasion in Testicular Cancer: Insights from Multi-Omics Analysis and Immunotherapeutic Validation
by: Congcong Xu, et al.
Published: (2025-07-01)

Melanophilin inhibit the growth and lymph node metastasis of triple negative breast cancer via the NONO-SPHK1-S1P axis
by: Xing Yao, et al.
Published: (2025-03-01)

METTL3/IGF2BP2 Promotes the Malignant Progression of Esophageal Cancer by Activating the PIK3CA/AKT Pathway
by: Xinmeng Guo, et al.
Published: (2025-02-01)

Zmiany w stężeniach insulinopodobnych czynników wzrostu IGF-1 i IGF-2 i białek wiążących BP-2 i BP-3 w czasie leczenia ostrej białaczki limfoblastycznej
by: Maryna Krawczuk-Rybak, et al.
Published: (2004-03-01)

Exploring CISD1 as a multifaceted biomarker in cancer: Implications for diagnosis, prognosis, and immunotherapeutic response
by: Caiyue Li, et al.
Published: (2025-11-01)

IGF2BP2‐induced circRNF20 facilitates breast cancer cell proliferation via the HuR/CDCA4 axis
by: Shu‐Tao Wu, et al.
Published: (2025-05-01)

IGF2BP3 as a Novel Prognostic Biomarker and Therapeutic Target in Lung Adenocarcinoma
by: Feiming Hu, et al.
Published: (2025-08-01)

Polystyrene microspheres could inhibit the ferroptosis of prostate cancer cells via USP39/IGF2BP3/MAPK4 axis
by: Shengming Lu, et al.
Published: (2025-08-01)

CYFIP2: potential pancreatic cancer biomarker and immunotherapeutic target
by: Cong Xiao, et al.
Published: (2024-12-01)

SphK1/S1P信号通路在肾脏疾病中的作用
by: 呼延逸然, et al.
Published: (2023-01-01)

CircATP5C1 promotes triple-negative breast cancer progression by binding IGF2BP2 to modulate CSF-1 secretion
by: Hongbo Liu, et al.
Published: (2025-12-01)

The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
by: Jing Zhang, et al.
Published: (2025-01-01)

IGF2BP3 As a Prognostic Biomarker and Regulator of Metastasis in Merkel Cell Carcinoma
by: Yajie Yang, et al.
Published: (2025-05-01)

CircRNA aptamer targets IGF2BP2 to overcome acquired BETi resistance
by: Christophe Nicot
Published: (2025-08-01)

Next-generation immunotherapeutic approaches for blood cancers: Exploring the efficacy of CAR-T and cancer vaccines
by: Kiavash Hushmandi, et al.
Published: (2025-05-01)

The potential of ME1 in guiding immunotherapeutic strategies for ovarian cancer: insights from pan-cancer research
by: Jiahui Wei, et al.
Published: (2025-05-01)

Lactylation Modification as a Promoter of Bladder Cancer: Insights from Multi-Omics Analysis
by: Yipeng He, et al.
Published: (2024-11-01)